Squibb announced the oral presentation of the first disclosure of the safety and efficacy data from the global ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

World first study of novel antibody therapeutic in peanut allergic individuals using the proprietary SEQ SIFTER™ antibody discovery platform now fully enrolled SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

Cordova City Council members approved last Tuesday night a resolution awarding a bid for Phase 1 of a RAISE paving project ...

Capsida Biotherapeutics has paused a gene therapy trial after the first patient died. The biotech, which began the phase 1/2 study in July, took the action to give it time to determine the “root cause ...

NEW YORK--(BUSINESS WIRE)--Standard Chartered (the “Bank”) today announced its pivotal role in the successful closing of a USD15.1 billion financing for the first phase of Venture Global, Inc.'s CP2 ...

DUBLIN, Sept. 7, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 ...